Brief: Medicenna Reports First Quarter Fiscal 2022 Financial Results And Operational Highlights
13/08/2021 12:26
Aug 13 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS FIRST QUARTER FISCAL 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* MEDICENNA THERAPEUTICS CORP QTRLY LOSS PER SHARE $0.12
* MEDICENNA THERAPEUTICS - FUNDS AS OF JUNE 30, 2021 PROVIDE
CO
SUFFICIENT CAPITAL TO EXECUTE CURRENT PLANNED EXPENDITURES
THROUGH END OF CALENDAR 2022
Source text for Eikon: ID:nGNX2gSnMD
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results